Insulin Glargine vs DPDPE

Head-to-head comparison of Insulin Glargine (Insulin glargine (A21Gly,B31Arg,B32Arg human insulin analog)) and DPDPE ([D-Pen2, D-Pen5]-enkephalin) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyInsulin GlargineDPDPE
CategoryDiabetes & MetabolicPain Management
Full NameInsulin glargine (A21Gly,B31Arg,B32Arg human insulin analog)[D-Pen2, D-Pen5]-enkephalin
Molecular Weight6063.6 Da645.79 Da
Half-LifeAbout 12-24 hours15-60 minutes in plasma
Amino Acids515
Typical Dose0.1-0.2 U/kg once daily0.01-1 ug per animal
RouteSubcutaneousIntrathecal / intracerebroventricular
Purity≥98%≥98%
Studies Count13000800
Research StatusApprovedPre-clinical

Insulin Glargine Benefits

  • Once-daily basal coverage
  • Smooth action profile
  • Lower nocturnal hypoglycemia risk
  • Improves fasting glucose control

DPDPE Benefits

  • delta-opioid selectivity
  • improved conformational stability
  • analgesic receptor mapping
  • useful in chronic pain models

Insulin Glargine Dosing

Inject SC once daily at the same time each day|Titrate every 3-4 days to fasting glucose targets|Can be combined with prandial insulin

DPDPE Dosing

Intrathecal 0.01-1 ug per animal|Intracerebroventricular 0.01-0.5 ug per animal|In vitro 0.1-20 nM

Insulin Glargine Side Effects

  • Hypoglycemia
  • Injection-site reactions
  • Weight gain

DPDPE Side Effects

  • sedation
  • nausea-like opioid effects
  • tolerance with repeated dosing

Research Overview

Insulin Glargine

Clinical and translational studies support its use as a basal comparator because of prolonged absorption and stable glycemic control. It is heavily used in basal-bolus regimen research and insulin-delivery optimization studies.

DPDPE

DPDPE is widely cited in opioid pharmacology because it helped establish the functional role of delta-opioid receptors in pain control. Its constrained structure is also used to explore how peptide cyclization changes potency, stability, and tissue selectivity.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Insulin Glargine stacks with:

Insulin LisproInsulin Aspart

DPDPE stacks with:

morphinegabapentin
basal insulinlong-actingfasting glucosecyclic-peptidedelta-opioidanalgesiaenkephalin-analog